Article - 30/07/2009 Tikanis GmbH Freiburg – flexible modelling and planning software Experiments in modern cell biological laboratories or the scheduling and task management of rehab clinics – all of this leads to a flood of data, which needs to be organised and analysed. The Freiburg-based start-up company Tikanis GmbH offers innovative and inexpensive software solutions for modellers of dynamic processes, clinical researchers or therapists. The founders of the company, Dr. Thomas Maiwald and Julie Blumberg, are well aware of…https://www.gesundheitsindustrie-bw.de/en/article/news/tikanis-gmbh-freiburg-flexible-modelling-and-planning-software
Article - 30/07/2009 Keeping as many valuable attachments as possible The goal of many projects focusing on the purification of recombinant proteins is to rapidly and effectively remove substances and side products that would compromise the quality and quantity of biopharmaceutical compounds. A consortium of industrial and scientific partners is currently focusing on a different step in the biopharmaceutical production process: the goal is to keep as many as possible of the drugs’ ‘attachments’. The project focuses…https://www.gesundheitsindustrie-bw.de/en/article/news/keeping-as-many-valuable-attachments-as-possible
Dossier - 30/07/2009 Downstream processing: bottleneck purification process The fermentation processes that are used by biopharmaceutical manufacturers have shown to lead to increasing quantities of therapeutic proteins. However this increase in turn leads to capacity bottlenecks in the subsequent purification process known as downstream processing and is associated with high costs. Downstream processing comprises up to 80 per cent of the entire production costs. Producers are increasingly recognising the present need…https://www.gesundheitsindustrie-bw.de/en/article/dossier/downstream-processing-bottleneck-purification-process
Press release - 29/07/2009 Second roundtable discussions dealing with plant genetics “Today, we have made good progress. The talks were very focused and intensive,” said the German Federal Research Minister Annette Schavan, summarising what had been achieved at the second green genetic engineering roundtable in Berlin attended by invited representatives from science, the agricultural and food industries, environmental associations and churches. https://www.gesundheitsindustrie-bw.de/en/article/press-release/second-roundtable-discussions-dealing-with-plant-genetics
Article - 29/07/2009 Protein crystallisation: an attractive alternative to protein purification The production of pure crystals is a method that is normally used for the determination of the spatial structure of a protein using X-ray defraction. Crystalline proteins have a very regular structure, meaning that contaminations can to a large extent be excluded. Therefore, protein crystals only contain a small number of foreign substances, which makes them a lot more stable in solution than proteins are. Due to the aforementioned properties,…https://www.gesundheitsindustrie-bw.de/en/article/news/protein-crystallisation-an-attractive-alternative-to-protein-purification
Press release - 29/07/2009 EU Commission steps up action on Alzheimer's disease and other neurodegenerative conditions On July the 22nd of 2009, the European Commission adopted concrete proposals to tackle Alzheimer’s disease, dementias and other neurodegenerative conditions. These shared health and social challenges in Europe call for coordinated actions to ensure efficient prevention, diagnosis, treatment and care for those affected.https://www.gesundheitsindustrie-bw.de/en/article/press-release/eu-commission-steps-up-action-on-alzheimer-s-disease-and-other-neurodegenerative-conditions
Press release - 28/07/2009 First intranasal fentanyl approved in Europe for managing breakthrough pain in cancer Nycomed announced that the European Commission has granted marketing authorisation for Instanyl its first-in-class intranasal fentanyl spray. Instanyl is aimed at managing breakthrough pain in adult cancer patients already receiving maintenance opioid therapy for chronic pain.https://www.gesundheitsindustrie-bw.de/en/article/press-release/first-intranasal-fentanyl-approved-in-europe-for-managing-breakthrough-pain-in-cancer
Press release - 28/07/2009 Fostering enthusiasm for successful entrepreneurship BioRegio STERN Management GmbH has honoured the winning projects in the regional “Science2Start” competition. A panel of experts awarded a total of 2,250 euros for the most innovative ideas with marketing potential. The winners celebrated their success with approx. 240 visitors of the annual summer event jointly organised by BioRegio STERN Management GmbH, the Society for the Promotion of Biotechnology Stuttgart/Tübingen/Neckar-Alb e.V. and PUSH!…https://www.gesundheitsindustrie-bw.de/en/article/press-release/fostering-enthusiasm-for-successful-entrepreneurship
Press release - 28/07/2009 New Forces for Protein Research Heidelberg research institute EML Research is pleased to announce that as of July 15, Dr. Frauke Gräter will be group leader of a newly established research group called “Molecular Biomechanics“. The 32 year old chemist has been junior research group leader jointly at the Bioquant, University of Heidelberg, and the MPG-CAS Partner Institute for Computational Biology (PICB), Shanghai, since 2007. Before that, she had worked at Columbia University,…https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-forces-for-protein-research
Press release - 28/07/2009 New trachea made from human tissue A team of doctors from the Schillerhöhe Hospital, which is part of the Robert Bosch Hospital in Stuttgart, in cooperation with researchers from the Fraunhofer Institute of Interfacial Engineering and Biotechnology IGB in Stuttgart, has developed a method that enables artificially produced autologous tissue to be implanted into patients with severe tracheal injuries. The method involves the cultivation of extensive parts of the human trachea and…https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-trachea-made-from-human-tissue
Press release - 23/07/2009 Mannheim Medical Centre – leading cancer laboratory and clinical research centre Mannheim is the only medical centre in Germany to fulfil the criteria of an affiliated centre of EORTC. According to a recent EORTC report Mannheim is the only German centre that has fulfilled the organisations high quality criteria over the last three years. https://www.gesundheitsindustrie-bw.de/en/article/press-release/mannheim-medical-centre-leading-cancer-laboratory-and-clinical-research-centre
Article - 23/07/2009 Making cancer cells commit suicide They divide and divide, and no natural border can stop them. Tumours such as the Ewing sarcoma, a bone cancer that occurs predominantly in teenagers, grow incessantly, making treatment difficult. A few years ago, Prof. Dr. Udo Kontny and his team from the University Hospital in Freiburg discovered a way to stop the growth of this particular tumour by activating a switch on the surface of cells which induces cellular death. Can physicians learn to…https://www.gesundheitsindustrie-bw.de/en/article/news/making-cancer-cells-commit-suicide
Press release - 23/07/2009 Michael Reth to receive Schering-Plough research prize The spokesperson of the “bioss” excellence cluster has been awarded the EFIS-Schering-Plough European Immunology Prize for his research into immune cell signalling processes. The European Federation of Immunological Societies’ EFIS-Schering-Plough European Immunology Prize, which recognises individuals who have made an outstanding discovery in the field of immune research, has now been awarded for the second time. https://www.gesundheitsindustrie-bw.de/en/article/press-release/michael-reth-to-receive-schering-plough-research-prize
Press release - 23/07/2009 First Catalog Cancer Biochip for Sequence Capture Now Available from febit febit holding gmbh announced today the launch of the first human cancer biochip for HybSelectâ, febit’s highly automated technology for sequence capture, enabling targeted Next-Generation Sequencing (NGS). The new catalog cancer biochip features 115 important genes which are reported to be associated with common types of cancer by the Wellcome Trust Sanger Institute. https://www.gesundheitsindustrie-bw.de/en/article/press-release/first-catalog-cancer-biochip-for-sequence-capture-now-available-from-febit
Press release - 23/07/2009 “We wanted to change the world” – the success story of Genzyme The CEO of Genzyme, Henri Termeer, explains how a young company, “which had no ideas” managed to become an internationally successful company with 11,000 employees in around 40 countries: “Ideas that other people think you are crazy to have, are usually the ideas that are the most successful.” The company's subsidiary in the city of Constance has 27 employees.https://www.gesundheitsindustrie-bw.de/en/article/press-release/we-wanted-to-change-the-world-the-success-story-of-genzyme
Press release - 20/07/2009 University Medical Centre Freiburg coordinates popular DFG priority programme The German Research Foundation (DFG) has granted the Medical Hospital in Freiburg and the German Cancer Research Centre in Heidelberg funding for a proposal applying to become one of the DFG’s 18 priority programmes in 2009. https://www.gesundheitsindustrie-bw.de/en/article/press-release/university-medical-centre-freiburg-coordinates-popular-dfg-priority-programme
Press release - 17/07/2009 Investigation of living cellular complexes with the fastest nano light microscope in the world Prof. Dr. Dr. Christoph Cremer of the Kirchhoff Institute of Physics at the University of Heidelberg and his team have developed a high-performance microscope. This cutting edge microscope enables scientists to investigate molecular details of several cells simultaneously using standard fluorescent dyes such as green fluorescent protein (GFP). The world’s fastest nano light microscope uses a new localisation microscope method known as spectral…https://www.gesundheitsindustrie-bw.de/en/article/press-release/investigation-of-living-cellular-complexes-with-the-fastest-nano-light-microscope-in-the-world
Dossier - 16/07/2009 Patents – the exploitations of inventions in the life sciences According to statistics from the European Patent Office a total of 1065 biotechnological patents were filed in 2007 by inventors based in Germany. This puts Germany second behind the USA. In the coming years experts expect that a much larger number of biotech patents will be filed. For life sciences inventors the registration of patents quite often represents a real challenge. People entering the world of patents and licences are faced with a…https://www.gesundheitsindustrie-bw.de/en/article/dossier/patents-the-exploitations-of-inventions-in-the-life-sciences
Article - 15/07/2009 The gap in the value creation chain On a national level the University of Freiburg comes out reasonably well in comparison with other universities regarding the number of patents filed and licensed. But is it enough to protect an intellectual property and sell it to a company? No says Prof. Dr. Bernhard Arnolds from the Central Office of Research Funding and Technology Transfer at the University of Freiburg.https://www.gesundheitsindustrie-bw.de/en/article/news/the-gap-in-the-value-creation-chain
Article - 14/07/2009 Tiny particles are a weapon against tumours Prostate carcinoma is one of the most common malignant diseases claiming more than 84000 lives per year in the EU and the United States. In cooperation with the University of Constance the Thurgau Biotechnology Institute BITg is working on ways to remove prostate carcinomas and other tumours that are difficult to treat by using tiny particles made of biologically degradable polyester. Prof. Dr. Marcus Groettrup and his team of researchers have…https://www.gesundheitsindustrie-bw.de/en/article/news/tiny-particles-are-a-weapon-against-tumours
Press release - 14/07/2009 Amedrix GmbH - Successful cell-free products The cell biologist Dr. Thomas Graeve has founded Amedrix GmbH in Esslingen. In future, the company will develop and produce innovative, cell-free medical products based on animal collagen for the purpose of wound regeneration and the reconstruction of degenerated soft tissue, for example. https://www.gesundheitsindustrie-bw.de/en/article/press-release/amedrix-gmbh-successful-cell-free-products
Article - 14/07/2009 Nicole Radde brings dynamism to research into cellular processes Using mathematical analyses systems biology simulates dynamic processes inside living cells. What happens when. is a question that researchers are looking to answer in future using such models. As junior professor of systems theory in systems biology at the University of Stuttgart it is Nicole Raddes task to establish this field of research at the university.https://www.gesundheitsindustrie-bw.de/en/article/news/nicole-radde-brings-dynamism-to-research-into-cellular-processes
Press release - 13/07/2009 Genome-wide study on the development of schizophrenia Numerous research centres around the world have been working together in order to clarify the genetic basis of schizophrenia. The Central Institute of Mental Health (ZI) in Mannheim was also involved in the study, which was recently published online in the scientific journal Nature.https://www.gesundheitsindustrie-bw.de/en/article/press-release/genome-wide-study-on-the-development-of-schizophrenia
Press release - 10/07/2009 New genes that regulate the cholesterol metabolism Scientists from the University Hospital of Heidelberg and the European Molecular Biology Laboratory (EMBL) have identified 20 new genes that are involved in the uptake of cholesterol into the cells. Twelve of these genes had previously been unknown. The findings are of great importance for the understanding of the regulation of cholesterol level and they make an important contribution to the treatment of coronary heart disease.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-genes-that-regulate-the-cholesterol-metabolism
Press release - 10/07/2009 How to make tumour cells undergo suicide? How to make tumour cells undergo suicide? The pathologist Dr. Wilfried Roth was awarded the Rudolf Virchow Prize and a cheque of 5000 euros for his work on inducing apoptosis in tumour cells. https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-to-make-tumour-cells-undergo-suicide